Results 261 to 270 of about 560,572 (303)

Adrenergic blockade

American Heart Journal, 1960
openaire   +2 more sources

Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses

Immunity, 2022
Xiaozheng Xu, Enfu Hui, Eric J Bennett
exaly  

Blockade

2018
L. A. Atherley-Jones, Hugh H. L. Bellot
openaire   +2 more sources

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade

Cancer Cell, 2020
Robert Motzer, Thomas Powles, Mahrukh A Huseni   +2 more
exaly  

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types

Annals of Oncology, 2021
Mustafa Khasraw, Bora Lim, E Jonasch
exaly  

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

Cell, 2017
Alexandria P. Cogdill, James P. Allison, Spencer C Wei   +2 more
exaly  

Non-conventional Inhibitory CD4+Foxp3−PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity

Cancer Cell, 2018
Jedd D. Wolchok, Alexander C Huang, Taha Merghoub   +2 more
exaly  

Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade

Cell, 2018
Jedd D. Wolchok, Frank Stephen Hodi, Bastian Schilling   +2 more
exaly  

The Blockade

2023
openaire   +1 more source

Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer

Annals of Oncology, 2019
Hye Ryun Kim, Beung Chul Ahn, Hyo Sup Shim   +2 more
exaly